The Cooper Companies, Inc. $COO Position Trimmed by Weiss Asset Management LP

Weiss Asset Management LP trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 83.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 48,004 shares of the medical device company’s stock after selling 246,578 shares during the period. Weiss Asset Management LP’s holdings in Cooper Companies were worth $3,434,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. New York Life Investment Management LLC boosted its holdings in shares of Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares during the period. Root Financial Partners LLC raised its stake in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the period. Allworth Financial LP lifted its holdings in Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after acquiring an additional 167 shares during the last quarter. Blue Trust Inc. lifted its holdings in Cooper Companies by 13.9% in the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock worth $124,000 after acquiring an additional 185 shares during the last quarter. Finally, SJS Investment Consulting Inc. boosted its stake in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 187 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. JPMorgan Chase & Co. cut their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. Robert W. Baird reduced their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. Needham & Company LLC lowered their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. Finally, Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $81.85.

Cooper Companies Stock Performance

Shares of COO opened at $70.31 on Monday. The firm has a 50-day moving average price of $67.34 and a 200 day moving average price of $72.12. The firm has a market capitalization of $13.71 billion, a PE ratio of 59.58, a P/E/G ratio of 1.84 and a beta of 0.84. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the company earned $0.96 EPS. Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.